查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1403327

静脉血栓栓塞治疗市场：按设备、库存、应用、最终用户划分 - 全球预测（~2030 年）

Venous Thromboembolism Treatment Market by Device (Thrombectomy, Inferior Vena Cava Filter [Retrievable, Permanent], Stockings, Compression Pump) Application (DVT, Pulmonary Embolism) End User (Hospital, Ambulatory Care Center) - Global Forecast to 2030
出版日期: | 出版商: Meticulous Research | 英文 158 Pages | 订单完成后即时交付

价格

预计2030年全球静脉血栓栓塞治疗市场规模将达44亿美元，2023年至2030年复合年增长率为7.2%。

在对市场状况进行广泛的初级和二级研究以及深入分析后，本报告深入了解静脉血栓栓塞治疗市场的关键驱动因素、限制、挑战和机会。

静脉血栓栓塞的高发生率、癌症发生率的上升、糖尿病和肥胖等继发性危险因子的盛行率不断增加、骨科手术数量的增加以及对微创治疗手术的需求不断增加，是推动静脉血栓成长的关键因素。血栓栓塞治疗市场。此外，治疗方案的可用性和可负担性的提高、VTE诊断和治疗方法的进步以及新兴国家的市场扩张预计将为市场成长创造机会。

然而，产品缺陷和产品召回的情况可能会抑制市场成长。此外，缺乏对静脉血栓栓塞的认识以及对压缩衣副作用的认识不断增强是市场成长的主要挑战。

在本报告涵盖的设备中，血栓切除设备预计将在 2023 年占据静脉血栓栓塞治疗市场的最大份额。该细分市场的巨大市场份额是由于心血管疾病的盛行率不断上升、对微创手术的日益偏好以及新型血栓切除设备的推出。

在本报告涵盖的应用中，深部静脉血栓领域预计将在2023年占据静脉血栓栓塞治疗市场的最大份额。此细分市场的巨大市场份额是由于肥胖症盛行率不断上升、老年人口不断增加、生活方式相关疾病导致的深部静脉栓塞病例不断增加、过度饮酒以及对 DVT 的认识不断提高。

在本报告涵盖的最终用户中，医院部门预计将在 2023 年占据静脉血栓栓塞治疗市场的最大份额。这一巨大的市场份额归因于静脉血栓栓塞的盛行率不断上升、医院和诊所数量不断增加、高技能专业人员的存在以及医院的高购买力。前往医院的便利性以及大量患者在同一地点寻求全面医疗保健服务（包括诊断、治疗和手术）也有助于该细分市场占据巨大的市场份额。

全球静脉血栓栓塞治疗市场区域状况的详细分析为五个关键区域提供了详细的定性和定量见解：北美（美国、加拿大）、欧洲（德国、法国、亚太地区（中国、日本、印度）、拉丁美洲以及中东/非洲其他地区。

预计到2023年，北美将占据全球静脉血栓栓塞治疗市场的最大份额，其次是欧洲、亚太地区、拉丁美洲以及中东和非洲。然而，亚太地区预计在预测期内复合年增长率最高。该区域市场的成长是由慢性病盛行率上升、久坐生活方式的人数增加、医疗保健成本增加、政府旨在改善医疗基础设施的支持措施以及静脉血栓栓塞等因素所推动的。这被认为是由于以下因素造成的例如提高对该问题的认识。

目录

第一章简介

第二章研究方法

  • 调查先决条件

第三章执行摘要

第四章市场洞察

  • 概述
  • 促进者
    • 静脉血栓栓塞的发生率很高
    • 癌症发生率上升
  • 抑制因素
    • 产品缺陷和召回的发生
  • 机会
    • 提高治疗方案的可用性和可负担性
    • VTE诊断和治疗进展
  • 任务
    • 对静脉血栓栓塞缺乏认识

第五章静脉血栓栓塞治疗市场评估：依设备分类

  • 概述
  • 血栓清除装置
  • 下腔静脉过滤器
    • 可回收过滤器
    • 永久过滤器
  • 丝袜
  • 压缩帮浦
  • 其他设备/配件

第六章静脉血栓栓塞治疗市场评估：依应用分类

  • 概述
  • 深部静脉血栓（DVT）
  • 肺栓塞（PE）

第七章静脉血栓栓塞治疗市场评估：依最终用户

  • 概述
  • 医院
  • 门诊中心
  • 其他最终用户

第八章静脉血栓栓塞治疗市场评估：按地区

  • 概述
  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 亚太其他地区
  • 拉丁美洲
  • 中东/非洲

第 9 章 竞争分析

  • 概述
  • 主要成长策略
  • 竞争标桿
  • 比赛仪表板
    • 产业领导者
    • 市场差异化因素
    • 龙头企业
    • 启动
  • 市场份额分析（2022 年）
    • Boston Scientific Corporation（U.S.）
    • Stryker Corporation（U.S.）
    • Cardinal Health, Inc.（U.S.）
    • Enovis Corporation（U.S.）
    • Medtronic plc（Ireland）
    • Cook Group Incorporated（U.S.）

第十章公司简介

  • ALN Implants chirurgicaux（ALN Surgical Implants）
  • AngioDynamics, Inc.
  • Argon Medical Devices, Inc.
  • ArjoHuntleigh AB
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • Cook Group Incorporated
  • Koninklijke Philips N.V.
  • DS MAREF Co., Ltd
  • Enovis Corporation
  • LifeTech Scientific Corporation
  • Medtronic plc
  • Stryker Corporation

第十一章附录

Product Code: MRHC - 1041062

Venous Thromboembolism Treatment Market by Device (Thrombectomy, Inferior Vena Cava Filter [Retrievable, Permanent], Stockings, Compression Pump) Application (DVT, Pulmonary Embolism) End User (Hospital, Ambulatory Care Center) - Global Forecast to 2030.

The global venous thromboembolism treatment market is projected to reach $4.40 billion by 2030, at a CAGR of 7.2% from 2023 to 2030.

After conducting an extensive primary and secondary study and an in-depth analysis of the market scenario, this report offers insights into the key drivers, constraints, challenges, and opportunities within the venous thromboembolism treatment market.

The high prevalence of venous thromboembolism, rising incidence of cancer, growing prevalence of secondary risk factors such as diabetes and obesity, increase in orthopedic surgical procedures, and the rising demand for minimally invasive treatment procedures are the key factors driving the growth of the venous thromboembolism treatment market. Furthermore, the growing accessibility and affordability of treatment options, advancements in VTE diagnosis and treatment methods, and the market expansion in emerging economies are expected to create market growth opportunities.

However, instances of product failure and product recalls may restrain the market's growth. Additionally, lack of awareness about venous thromboembolism and increasing awareness of probable side effects of compression garments are major challenges for market growth.

Among the devices covered in this report, in 2023, the thrombectomy devices segment is expected to account for the largest share of the venous thromboembolism treatment market. The large market share of this segment is attributed to the increasing prevalence of cardiovascular diseases, growing preference for minimally invasive procedures, and launches of new thrombectomy devices.

Among the applications covered in this report, in 2023, the deep vein thrombosis segment is expected to account for the largest share of the venous thromboembolism treatment market. The large market share of this segment is attributed to the increasing prevalence of obesity, a growing geriatric population, rising cases of deep vein thrombosis due to lifestyle-related diseases, excessive alcohol consumption, and heightened awareness of DVT.

Among the end users covered in this report, in 2023, the hospitals segment is expected to account for the largest share of the venous thromboembolism treatment market. The large market share is attributed to the increasing prevalence of venous thromboembolism, the rising number of hospitals and clinics, the presence of highly skilled professionals, and the high purchasing power of hospitals. The easy accessibility to hospitals, coupled with a large patient population seeking comprehensive healthcare services, including diagnosis, treatment, and surgeries at a single location, also contributes to the significant market share of this segment.

An in-depth analysis of the geographical scenario of the global venous thromboembolism treatment market provides detailed qualitative and quantitative insights into the five major geographies: North America (U.S., Canada), Europe (Germany, France, U.K., Italy, Spain, Rest of Europe), Asia-Pacific (China, Japan, India), Latin America, and the Middle East & Africa.

In 2023, North America is expected to account for the largest share of the global venous thromboembolism treatment market, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. However, Asia-Pacific is slated to register the largest CAGR during the forecast period. The growth of this regional market can be attributed to factors such as the growing prevalence of chronic diseases, the increasing number of people living sedentary lifestyles, growing health expenditures, supportive government initiatives aimed at improving healthcare infrastructure, and rising awareness regarding venous thromboembolism.

The key players operating in the global venous thromboembolism treatment market are ALN Implants chirurgicaux (ALN Surgical Implants) (France), AngioDynamics, Inc. (U.S.), Argon Medical Devices, Inc. (U.S.), ArjoHuntleigh AB (Sweden), Boston Scientific Corporation (U.S.), Cardinal Health, Inc. (U.S.), Cook Group Incorporated (U.S.), Koninklijke Philips N.V. (Netherlands), DS MAREF Co., LTD (South Korea), Enovis Corporation (U.S.), LifeTech Scientific Corporation (China), Medtronic plc (Ireland), and Stryker Corporation (U.S.).

Scope of the Report:

Venous Thromboembolism Treatment Market Assessment-by Device

  • Thrombectomy Devices
  • Inferior Vena Cava Filters
    • Retrievable Filters
    • Permanent Filters
  • Stockings
  • Compression Pumps
  • Other Devices & Accessories

Note: Other devices & accessories include extraction and repositioning devices for vena cava filters and garments for compression therapy (excluding stockings).

Venous Thromboembolism Treatment Market Assessment-by Application

  • Deep Vein Thrombosis
  • Pulmonary Embolism

Venous Thromboembolism Treatment Market Assessment-by End User

  • Hospitals
  • Ambulatory Care Centers
  • Other End Users

Note: Other end users include nursing care centers, long-term care centers, and military health centers.

Venous Thromboembolism Treatment Market Assessment-by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia-Pacific (APAC)
    • China
    • Japan
    • India
    • Rest of APAC (RoAPAC)
  • Latin America
  • Middle East & Africa

TABLE OF CONTENTS

1. Introduction

  • 1.1. Market Definition & Scope
  • 1.2. Market Ecosystem
  • 1.3. Currency & Limitations
  • 1.4. Key Stakeholders

2. Research Methodology

  • 2.1. Research Process
  • 2.2. Process of Data Collection & Validation
    • 2.2.1. Secondary Research
    • 2.2.2. Primary Research/Interviews With Key Opinion Leaders of the Industry
  • 2.3. Market Sizing and Forecasting
    • 2.3.1. Market Size Estimation
      • 2.3.1.1. Bottom-Up Approach
      • 2.3.1.2. Top-Down Approach
      • 2.3.1.3. Growth Forecast Approach
    • 2.3.2. Market Share Analysis
  • 2.4. Assumptions for the Study

3. Executive Summary

4. Market Insights

  • 4.1. Overview
  • 4.2. Drivers
    • 4.2.1. High Prevalence of Venous Thromboembolism
    • 4.2.2. Rising Incidence of Cancer
  • 4.3. Restraints
    • 4.3.1. Instances of Product Failure and Product Recalls
  • 4.4. Opportunities
    • 4.4.1. Growing Accessibility and Affordability of Treatment Options
    • 4.4.2. Advancements in VTE Diagnosis and Treatment Methods
  • 4.5. Challenges
    • 4.5.1. Lack of Awareness About Venous Thromboembolism

5. Venous Thromboembolism Treatment Market Assessment-by Device

  • 5.1. Overview
  • 5.2. Thrombectomy Devices
  • 5.3. Inferior Vena Cava Filters
    • 5.3.1. Retrievable Filters
    • 5.3.2. Permanent Filters
  • 5.4. Stockings
  • 5.5. Compression Pumps
  • 5.6. Other Devices & Accessories

6. Venous Thromboembolism Treatment Market Assessment-by Application

  • 6.1. Overview
  • 6.2. Deep Vein Thrombosis (DVT)
  • 6.3. Pulmonary Embolism (PE)

7. Venous Thromboembolism Treatment Market Assessment-by End User

  • 7.1. Overview
  • 7.2. Hospitals
  • 7.3. Ambulatory Care Centers
  • 7.4. Other End Users

8. Venous Thromboembolism Treatment Market Assessment-by Geography

  • 8.1. Overview
  • 8.2. North America
    • 8.2.1. U.S.
    • 8.2.2. Canada
  • 8.3. Europe
    • 8.3.1. Germany
    • 8.3.2. France
    • 8.3.3. U.K.
    • 8.3.4. Italy
    • 8.3.5. Spain
    • 8.3.6. Rest of Europe
  • 8.4. Asia-Pacific
    • 8.4.1. China
    • 8.4.2. Japan
    • 8.4.3. India
    • 8.4.4. Rest of Asia-Pacific
  • 8.5. Latin America
  • 8.6. Middle East & Africa

9. Competition Analysis

  • 9.1. Overview
  • 9.2. Key Growth Strategies
  • 9.3. Competitive Benchmarking
  • 9.4. Competitive Dashboard
    • 9.4.1. Industry Leaders
    • 9.4.2. Market Differentiators
    • 9.4.3. Vanguards
    • 9.4.4. Emerging Companies
  • 9.5. Market Share Analysis (2022)
    • 9.5.1. Boston Scientific Corporation (U.S.)
    • 9.5.2. Stryker Corporation (U.S.)
    • 9.5.3. Cardinal Health, Inc. (U.S.)
    • 9.5.4. Enovis Corporation (U.S.)
    • 9.5.5. Medtronic plc (Ireland)
    • 9.5.6. Cook Group Incorporated (U.S.)

10. Company Profiles

  • 10.1. ALN Implants chirurgicaux (ALN Surgical Implants)
  • 10.2. AngioDynamics, Inc.
  • 10.3. Argon Medical Devices, Inc.
  • 10.4. ArjoHuntleigh AB
  • 10.5. Boston Scientific Corporation
  • 10.6. Cardinal Health, Inc.
  • 10.7. Cook Group Incorporated
  • 10.8. Koninklijke Philips N.V.
  • 10.9. DS MAREF Co., Ltd
  • 10.10. Enovis Corporation
  • 10.11. LifeTech Scientific Corporation
  • 10.12. Medtronic plc
  • 10.13. Stryker Corporation

11. Appendix

  • 11.1. Available Customization
  • 11.2. Related Reports
  • Table 1 Share of Population Aged 65 Years or Above, by Region, 2022 Vs. 2030 Vs. 2050
  • Table 2 Number of New Cancer Cases, by Type, 2020 Vs. 2030
  • Table 3 Global Venous Thromboembolism Treatment Market, by Device, 2021-2030 (USD Million)
  • Table 4 Global Venous Thromboembolism Treatment Market for Thrombectomy Devices, by Country/Region, 2021-2030 (USD Million)
  • Table 5 Global Venous Thromboembolism Treatment Market for Inferior Vena Cava Filters, by Type, 2021-2030 (USD Million)
  • Table 6 Global Venous Thromboembolism Treatment Market for Inferior Vena Cava Filters, by Country/Region, 2021-2030 (USD Million)
  • Table 7 Global Retrievable Filters Market, by Country/Region, 2021-2030 (USD Million)
  • Table 8 Global Permanent Filters Market, by Country/Region, 2021-2030 (USD Million)
  • Table 9 Global Venous Thromboembolism Treatment Market for Stockings, by Country/Region, 2021-2030 (USD Million)
  • Table 10 Global Venous Thromboembolism Treatment Market for Compression Pumps, by Country/Region, 2021-2030 (USD Million)
  • Table 11 Global Venous Thromboembolism Treatment Market for Other Devices & Accessories, by Country/Region, 2021-2030 (USD Million)
  • Table 12 Global Venous Thromboembolism Treatment Market, by Application, 2021-2030 (USD Million)
  • Table 13 Global Venous Thromboembolism Treatment Market for Deep Vein Thrombosis (DVT), by Country/Region, 2021-2030 (USD Million)
  • Table 14 Global Venous Thromboembolism Treatment Market for Pulmonary Embolism (PE), by Country/Region, 2021-2030 (USD Million)
  • Table 15 Venous Thromboembolism Treatment Market, by End User, 2021-2030 (USD Million)
  • Table 16 Global Venous Thromboembolism Treatment Market for Hospitals, by Country/Region, 2021-2030 (USD Million)
  • Table 17 Global Venous Thromboembolism Market for Ambulatory Care Centers, by Country/Region, 2021-2030 (USD Million)
  • Table 18 Global Venous Thromboembolism Market for Other End Users, by Country/Region, 2021-2030 (USD Million)
  • Table 19 Global Venous Thromboembolism Treatment Market, by Country/Region, 2021-2030 (USD Million)
  • Table 20 North America: Venous Thromboembolism Treatment Market, by Country, 2021-2030 (USD Million)
  • Table 21 North America: Venous Thromboembolism Treatment Market, by Device, 2021-2030 (USD Million)
  • Table 22 North America: Inferior Vena Cava Filters Market, by Type, 2021-2030 (USD Million)
  • Table 23 North America: Venous Thromboembolism Treatment Market, by Application, 2021-2030 (USD Million)
  • Table 24 North America: Venous Thromboembolism Treatment Market, by End User, 2021-2030 (USD Million)
  • Table 25 U.S.: Venous Thromboembolism Treatment Market, by Device, 2021-2030 (USD Million)
  • Table 26 U.S.: Inferior Vena Cava Filters Market, by Type, 2021-2030 (USD Million)
  • Table 27 U.S.: Venous Thromboembolism Treatment Market, by Application, 2021-2030 (USD Million)
  • Table 28 U.S.: Venous Thromboembolism Treatment Market, by End User, 2021-2030 (USD Million)
  • Table 29 Canada: Prevalence of Diseases/Conditions in The Geriatric (Age 65 Years And Above) Population (2019-2020)
  • Table 30 Canada: Venous Thromboembolism Treatment Market, by Device, 2021-2030 (USD Million)
  • Table 31 Canada: Inferior Vena Cava Filters Market, by Type, 2021-2030 (USD Million)
  • Table 32 Canada: Venous Thromboembolism Treatment Market, by Application, 2021-2030 (USD Million)
  • Table 33 Canada: Venous Thromboembolism Treatment Market, by End User, 2021-2030 (USD Million)
  • Table 34 Europe: Venous Thromboembolism Treatment Market, by Country/Region, 2021-2030 (USD Million)
  • Table 35 Europe: Venous Thromboembolism Treatment Market, by Device, 2021-2030 (USD Million)
  • Table 36 Europe: Inferior Vena Cava Filters Market, by Type, 2021-2030 (USD Million)
  • Table 37 Europe: Venous Thromboembolism Treatment Market, by Application, 2021-2030 (USD Million)
  • Table 38 Europe: Venous Thromboembolism Treatment Market, by End User, 2021-2030 (USD Million)
  • Table 39 Germany: Venous Thromboembolism Treatment Market, by Device, 2021-2030 (USD Million)
  • Table 40 Germany: Inferior Vena Cava Filters Market, by Type, 2021-2030 (USD Million)
  • Table 41 Germany: Venous Thromboembolism Treatment Market, by Application, 2021-2030 (USD Million)
  • Table 42 Germany: Venous Thromboembolism Treatment Market, by End User, 2021-2030 (USD Million)
  • Table 43 France: Venous Thromboembolism Treatment Market, by Device, 2021-2030 (USD Million)
  • Table 44 France: Inferior Vena Cava Filters Market, by Type, 2021-2030 (USD Million)
  • Table 45 France: Venous Thromboembolism Treatment Market, by Application, 2021-2030 (USD Million)
  • Table 46 France: Venous Thromboembolism Treatment Market, by End User, 2021-2030 (USD Million)
  • Table 47 U.K.: Venous Thromboembolism Treatment Market, by Device, 2021-2030 (USD Million)
  • Table 48 U.K.: Inferior Vena Cava Filters Market, by Type, 2021-2030 (USD Million)
  • Table 49 U.K.: Venous Thromboembolism Treatment Market, by Application, 2021-2030 (USD Million)
  • Table 50 U.K.: Venous Thromboembolism Treatment Market, by End User, 2021-2030 (USD Million)
  • Table 51 Italy: Venous Thromboembolism Treatment Market, by Device, 2021-2030 (USD Million)
  • Table 52 Italy: Inferior Vena Cava Filters Market, by Type, 2021-2030 (USD Million)
  • Table 53 Italy: Venous Thromboembolism Treatment Market, by Application, 2021-2030 (USD Million)
  • Table 54 Italy: Venous Thromboembolism Treatment Market, by End User, 2021-2030 (USD Million)
  • Table 55 Spain: Venous Thromboembolism Treatment Market, by Device, 2021-2030 (USD Million)
  • Table 56 Spain: Inferior Vena Cava Filters Market, by Type, 2021-2030 (USD Million)
  • Table 57 Spain: Venous Thromboembolism Treatment Market, by Application, 2021-2030 (USD Million)
  • Table 58 Spain: Venous Thromboembolism Treatment Market, by End User, 2021-2030 (USD Million)
  • Table 59 Number of People Aged 56 And Above, by Country, 2012- 2022
  • Table 60 Estimated Number of New Cancer Cases, by Country, 2020 Vs. 2030
  • Table 61 RoE: Venous Thromboembolism Treatment Market, by Device, 2021-2030 (USD Million)
  • Table 62 RoE: Inferior Vena Cava Filters Market, by Type, 2021-2030 (USD Million)
  • Table 63 RoE: Venous Thromboembolism Treatment Market, by Application, 2021-2030 (USD Million)
  • Table 64 RoE: Venous Thromboembolism Treatment Market, by End User, 2021-2030 (USD Million)
  • Table 65 Asia-Pacific: Venous Thromboembolism Treatment Market, by Country/Region, 2021-2030 (USD Million)
  • Table 66 Asia-Pacific: Venous Thromboembolism Treatment Market, by Device, 2021-2030 (USD Million)
  • Table 67 Asia-Pacific: Inferior Vena Cava Filters Market, by Type, 2021-2030 (USD Million)
  • Table 68 Asia-Pacific: Venous Thromboembolism Treatment Market, by Application, 2021-2030 (USD Million)
  • Table 69 Asia-Pacific: Venous Thromboembolism Treatment Market, by End User, 2021-2030 (USD Million)
  • Table 70 China: Venous Thromboembolism Treatment Market, by Device, 2021-2030 (USD Million)
  • Table 71 China: Inferior Vena Cava Filters Market, by Type, 2021-2030 (USD Million)
  • Table 72 China: Venous Thromboembolism Treatment Market, by Application, 2021-2030 (USD Million)
  • Table 73 China: Venous Thromboembolism Treatment Market, by End User, 2021-2030 (USD Million)
  • Table 74 Japan: Venous Thromboembolism Treatment Market, by Device, 2021-2030 (USD Million)
  • Table 75 Japan: Inferior Vena Cava Filters Market, by Type, 2021-2030 (USD Million)
  • Table 76 Japan: Venous Thromboembolism Treatment Market, by Application, 2021-2030 (USD Million)
  • Table 77 Japan: Venous Thromboembolism Treatment Market, by End User, 2021-2030 (USD Million)
  • Table 78 India: Venous Thromboembolism Treatment Market, by Device, 2021-2030 (USD Million)
  • Table 79 India: Inferior Vena Cava Filters Market, by Type, 2021-2030 (USD Million)
  • Table 80 India: Venous Thromboembolism Treatment Market, by Application, 2021-2030 (USD Million)
  • Table 81 India: Venous Thromboembolism Treatment Market, by End User, 2021-2030 (USD Million)
  • Table 82 RoAPAC: Venous Thromboembolism Treatment Market, by Device, 2021-2030 (USD Million)
  • Table 83 RoAPAC: Inferior Vena Cava Filters Market, by Type, 2021-2030 (USD Million)
  • Table 84 RoAPAC: Venous Thromboembolism Treatment Market, by Application, 2021-2030 (USD Million)
  • Table 85 RoAPAC: Venous Thromboembolism Treatment Market, by End User, 2021-2030 (USD Million)
  • Table 86 Latin America: Venous Thromboembolism Treatment Market, by Device, 2021-2030 (USD Million)
  • Table 87 Latin America: Inferior Vena Cava Filters Market, by Type, 2021-2030 (USD Million)
  • Table 88 Latin America: Venous Thromboembolism Treatment Market, by Application, 2021-2030 (USD Million)
  • Table 89 Latin America: Venous Thromboembolism Treatment Market, by End User, 2021-2030 (USD Million)
  • Table 90 Middle East & Africa: Venous Thromboembolism Treatment Market, by Device, 2021-2030 (USD Million)
  • Table 91 Middle East & Africa: Inferior Vena Cava Filters Market, by Type, 2021-2030 (USD Million)
  • Table 92 Middle East & Africa: Venous Thromboembolism Treatment Market, by Application, 2021-2030 (USD Million)
  • Table 93 Middle East & Africa: Venous Thromboembolism Treatment Market, by End User, 2021-2030 (USD Million)
  • Table 94 Recent Developments, by Company (2020-2023)

LIST OF FIGURES

  • Figure 1 Research Process
  • Figure 2 Secondary Sources Referenced for this Study
  • Figure 3 Primary Research Techniques
  • Figure 4 Key Executives Interviewed
  • Figure 5 Breakdown of Primary Interviews (Supply-Side & Demand-Side)
  • Figure 6 Market Sizing and Growth Forecast Approach
  • Figure 7 Global Venous Thromboembolism Treatment Market, by Device, 2023 Vs. 2030 (USD Million)
  • Figure 8 Global Venous Thromboembolism Treatment Market, by Application, 2023 Vs. 2030 (USD Million)
  • Figure 9 Global Venous Thromboembolism Treatment Market, by End User, 2023 Vs. 2030 (USD Million)
  • Figure 10 Global Venous Thromboembolism Treatment Market, by Geography
  • Figure 11 Impact Analysis of Market Dynamics
  • Figure 12 Global Venous Thromboembolism Treatment Market, by Device, 2023 Vs. 2030 (USD Million)
  • Figure 13 Global Venous Thromboembolism Treatment Market, by Application, 2023 Vs. 2030 (USD Million)
  • Figure 14 Venous Thromboembolism Treatment Market, by End User, 2023 Vs. 2030 (USD Million)
  • Figure 15 Global Venous Thromboembolism Treatment Market, by Geography, 2023 Vs. 2030 (USD Million)
  • Figure 16 North America: Venous Thromboembolism Treatment Market Snapshot
  • Figure 17 Canada: Estimated Number of New Cancer Cases, 2020-2035
  • Figure 18 Europe: Venous Thromboembolism Treatment Market Snapshot
  • Figure 19 France: Percentage of Population Aged 65 Years and Above (2016-2022)
  • Figure 20 France: Prevalence of Chronic Diseases in People Aged 65 And Above (2020)
  • Figure 21 U.K.: Number of Diabetes And Urogenital, Blood, and Endocrine Disease Cases - DALYs (Disability-Adjusted Life Years), 2017-2020 (In Thousands)
  • Figure 22 Spain: Estimated Number of New Cancer Cases (2020-2035)
  • Figure 23 Switzerland: Number of New Cancer Cases Reported (2020-2040)
  • Figure 24 Asia-Pacific: Venous Thromboembolism Treatment Market Snapshot
  • Figure 25 Japan: Percentage Share of the Geriatric Population (Aged 65 Years And Above) (2015-2022)
  • Figure 26 Saudi Arabia: Number of People Aged 65 Years and Above, 2017-2021 (In Thousands)
  • Figure 27 South Africa: Number of People with Diabetes, 2000-2045 (In Thousands)
  • Figure 28 Key Growth Strategies Adopted by Leading Players 2020-2023
  • Figure 29 Venous Thromboembolism Treatment Market: Competitive Benchmarking, by Device
  • Figure 30 Venous Thromboembolism Treatment Market: Competitive Benchmarking, by Region
  • Figure 31 Competitive Dashboard: Venous Thromboembolism Treatment Market
  • Figure 32 Global Venous Thromboembolism Treatment Market Share Analysis, by Key Players (2022)
  • Figure 33 AngioDynamics, Inc.: Financial Overview (2023)
  • Figure 34 ArjoHuntleigh Ab: Financial Overview (2022)
  • Figure 35 Boston Scientific Corporation: Financial Overview (2022)
  • Figure 36 Cardinal, Inc.: Financial Overview (2022)
  • Figure 37 Koninklijke Philips N.V.: Financial Overview (2022)
  • Figure 38 Enovis Corporation: Financial Overview (2022)
  • Figure 39 LifeTech Scientific Corporation: Financial Overview (2022)
  • Figure 40 Medtronic plc: Financial Overview (2023)
  • Figure 41 Stryker Corporation: Financial Overview (2022)